- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01765075
Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment (STARLIGHT)
March 3, 2014 updated by: Boston Scientific Corporation
The purpose of the study is to gather electrophysiological data using a multi-electrode mapping catheter during a clinically indicated cardiac ablation procedure for the treatment of persistent atrial fibrillation.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
25
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Prague, Czech Republic, 15030
- Na Homolce
-
-
-
-
-
London, United Kingdom, SE1 1YR
- Guys & St. Thomas' Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Permanent atrial fibrillation
Description
Inclusion Criteria:
- Age 18 or above, or above legal age and willing and capable of giving informed consent specific to national law
- Scheduled for a clinically indicated cardiac ablation for the treatment of persistent atrial fibrillation
- Able to meet study requirements for follow-up visit
Exclusion Criteria:
- Permanent leads or presence of prosthetic or severely stenotic tricuspid or mitral valves
- Active systemic infection or sepsis
- Echocardiographically confirmed presence of thrombus
- Atrial thrombus, myxoma, inter-atrial baffle patch or occluder device for those subjects in whom a transseptal approach is required
- Subjects who cannot be anticoagulated or infused with heparinized saline
- Heparin induced thrombocytopenia
- Hemodynamic instability or shock
- Atrial anatomy contradictory to catheter labeling or size indices
- EF < 35%
- Subjects with an active heart failure decompensation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Patients undergoing cardiac ablation for permanent AF
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Record 20 sets of electrophysiological data with a multi-electrode mapping catheter.
Time Frame: Acute - time of procedure
|
Acute - time of procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jas Gill, MA MD FRCP FACC, Guys & St. Thomas' Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2013
Primary Completion (Actual)
February 1, 2014
Study Completion (Actual)
February 1, 2014
Study Registration Dates
First Submitted
January 8, 2013
First Submitted That Met QC Criteria
January 8, 2013
First Posted (Estimate)
January 10, 2013
Study Record Updates
Last Update Posted (Estimate)
March 5, 2014
Last Update Submitted That Met QC Criteria
March 3, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STARLIGHT - 1012
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Permanent Atrial Fibrillation
-
The University of Hong KongNot yet recruitingAtrial Fibrillation (AF) | Atrial Fibrillation (Permanent)Hong Kong
-
University of PalermoCompletedCongestive Heart Failure Chronic | Atrial Fibrillation (Permanent)Italy
-
Medtronic BRCMedtronicCompletedPermanent Atrial FibrillationItaly
-
Maastricht University Medical CenterNot yet recruitingAtrial Fibrillation | Pacemaker DDD | Paroxysmal Atrial Fibrillation | Persistent Atrial Fibrillation | Permanent Atrial Fibrillation
-
Asker & Baerum HospitalVestre Viken Hospital Trust; Helse Sor-OstCompletedAtrial Fibrillation | Permanent Atrial FibrillationNorway
-
Centro Prevenzione Malattie Cardiovascolari N....UnknownPermanent Atrial FibrillationItaly
-
University of BirminghamCompletedPermanent Atrial FibrillationUnited Kingdom
-
AstraZenecaCompletedPersistent or Permanent Nonvalvular Atrial Fibrillation
-
AstraZenecaCompletedPersistent or Permanent Non-valvular Atrial FibrillationSweden, Poland, Russian Federation, United Kingdom, Norway, Denmark
-
University of RochesterCompletedSystolic Heart Failure | Atrial Fibrillation (Permanent)United States